Charme IV makes its fifth investment with Tema Sinergie

Tema Sinergie produces isolators for nuclear medicine and the production of biotech pharmaceuticals.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.